Table 2.
Part | No. of questions | Topics | Scale |
---|---|---|---|
ctGD1-PROM and rmGD1-PROM | |||
1A | 4 | Restriction of activities, education, and work | 6-point verbal response scale |
1 | Concern about emotional burden | ||
1B | 2 | Context of GD concerns relating to general health and medication | 5-point verbal response scale |
1 | Context of GD concerns relating to other medical concerns | ||
2 | 1 | Dependence on others | 0–10 numeric rating scale |
6 | Presence/severity of symptoms | ||
1 | Satisfaction with treatment | ||
1 | Concern about the future | ||
rmGD1-PROM only | |||
6 | Concern about comorbidities, disease burden, and cost | 6-point verbal response scale | |
1 | Context of GD concerns relating to other medical concerns | 5-point verbal response scale |
ctGD1-PROM clinical trials (17-item) Gaucher disease type 1-specific patient-reported outcome measure questionnaire, GD Gaucher disease, rmGD1-PROM routine monitoring (24-item) GD1-specific patient-reported outcome measure questionnaire